Plasma surface treatment of ceramic particles has emerged as a promising approach for developing biocomposites intended for use in tissue engineering applications. Introducing functional groups on particle surfaces promotes changes in material surface properties, enhancing adhesion, biocompatibility, and reactivity. It can also mitigate degradation during the processing of polymer matrices in composite materials. Therefore, carefully choosing the functionalizing agent responsible for generating the functional groups and selecting appropriate functionalization parameters are significant steps in the plasma surface treatment process. However, in a tissue engineering context, an excess of the functionalizing agent can be harmful, increasing cell toxicity and inhibiting the stimulation of cell growth, consequently delaying or even hindering tissue regeneration. This article examines how the functionalizing agent excess of l-lactic acid (LA) applied in the plasma surface treatment of the filler affects the thermal, rheological, biological, and wettability properties of poly(lactic acid) (PLA) and zinc oxide (ZnO) biocomposites. The investigation reveals that the surface treatment effectively mitigated the catalytic effects of ZnO on PLA degradation during melt processing, regardless of the excess functionalizing agent. There was minimal impact on the material's rheological, thermal, and wettability characteristics, but the LA residue significantly influenced cell proliferation and the biological response. These findings show the importance of removing excess functionalizing agents to obtain biocomposites suitable for tissue engineering applications.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acsami.4c20196DOI Listing

Publication Analysis

Top Keywords

surface treatment
16
functionalizing agent
16
plasma surface
12
tissue engineering
12
excess functionalizing
12
excess l-lactic
8
l-lactic acid
8
engineering applications
8
functional groups
8
excess
5

Similar Publications

Adhesion-Assisted Antioxidant-Engineered Mesenchymal Stromal Cells for Enhanced Cardiac Repair in Myocardial Infarction.

ACS Nano

March 2025

School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou 511442, P. R. China.

Mesenchymal stromal cell (MSC) therapy holds great promise for treating myocardial infarction (MI). However, the inflammatory and reactive oxygen species (ROS)-rich environment in infarcted myocardium challenges MSC survival, limiting its therapeutic impact. In this study, we demonstrate that chemical modification of MSCs with anti-VCAM1 and polydopamine (PD) significantly enhances MSC survival and promotes cardiac repair.

View Article and Find Full Text PDF

Recalcitrant biofilm infections pose a great challenge to human health. Micro- and nanorobots have been used to eliminate biofilm infections in hard-to-reach regions inside the body. However, applying antibiofilm robots under physiological conditions is limited by the conflicting demands of accessibility and driving force.

View Article and Find Full Text PDF

Microfluidic isolation and release of live disseminated breast tumor cells in bone marrow.

PLoS One

March 2025

Department of Mechanical and Aerospace Engineering, Interdisciplinary Microsystems Group, Gainesville, Florida, United States of America.

Breast cancer represents a significant therapeutic challenge due to its aggressive nature and resistance to treatment. A major cause of treatment failure in breast cancer is the presence of rare, low-proliferative disseminated tumor cells (DTCs) in distant organs including the bone marrow. This study introduced a microfluidic-based approach to improve the immunodetection and isolation of these rare DTCs for downstream analysis, with an emphasis on optimizing immunocapture, release, and enrichment methods of live DTCs as compared to the standard approach for blood-borne circulating tumor cells (CTCs).

View Article and Find Full Text PDF

Vestibular deficits are common and debilitating, and many patients struggle with dynamic balance, even after treatment with standard rehabilitation techniques. The objective of this study was to measure changes in computerized dynamic posturography sensory ratio information after computerized vestibular retraining therapy (CVRT). This prospective, single-group, interventional study enrolled adult participants with stable, unilateral vestibular deficits.

View Article and Find Full Text PDF

Interferon alpha-2b versus 5-fluorouracil as primary treatment modalities for ocular surface squamous neoplasia: a study of 116 eyes.

Int Ophthalmol

March 2025

The Operation Eyesight Universal Institute for Eye Cancer, LV Prasad Eye Institute, L V Prasad Marg, Road no 2, Banjara Hills, Hyderabad, Telangana, 500034, India.

Purpose: To compare the efficacy and side-effect profile of interferon alpha-2b (IFNα2B) and topical 5-fluorouracil (5-FU) as primary treatment modalities for ocular surface squamous neoplasia (OSSN).

Methods: Retrospective comparative study of 116 OSSN eyes treated with topical 1 MIU IFNα2B with/without 5 MIU/cc subconjunctival injection (group 1) or topical 1% 5-FU (group 2) in mutually exclusive time periods of treatment.

Results: Of the 116 eyes with OSSN, 64 eyes belonged to group 1 and 52 eyes to group 2.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!